Metaclipse Therapeutics Corporation is a preclinical-stage biotechnology company
Metaclipse Therapeutics's investors include National Institutes of Health, Southern Research, Georgia Research Alliance.
Metaclipse Therapeutics is headquartered in Atlanta, United States.
Metaclipse Therapeutics Corporation is a preclinical-stage biotechnology company
Metaclipse Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Metaclipse Therapeutics — Funding & Investors." VCBacked, June 28, 2024, https://www.vcbacked.co/company/metaclipse-therapeutics. Accessed November 14, 2026.
VCBacked. (2024). Metaclipse Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/metaclipse-therapeutics
{{cite web |title=Metaclipse Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/metaclipse-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Metaclipse Therapeutics? Request a listing update